azpa Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Stiff penalties put pressure on drug distributors

In recent years, the actions of pharmaceutical drug distributors have garnered mainstream attention. As the toll of the opioid abuse continues to be felt in the U.S., manufacturers, doctors and pharmacies are starting to experience the consequences of their unsanctioned,...

source: By Dr. Abimbola Farinde
Search past issues
Search products and services

We would like to extend an invitation to an educational dinner program on May 30th in Chandler for your Pharmacist and Pharmacy Techs titled “Reassessing Endometriosis: Managing Unresolved Pain”. This disease state awareness program is being led by Dr. Hugh Taylor,...

source: AzPA

The Arizona Pharmacy Association Continuing Education Department is committed in offering high quality,...


Retail pharmacists and specialty pharmacists working in the trenches may have heard whispers about something...

source: Jason Poquette

The first warning came a dozen years ago, when the Food and Drug Administration accused drug company AstraZeneca of “false or misleading” information about health risks in marketing its blockbuster medication Seroquel,...

source: The Oakland Press

The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.

source: HealthDay News via Clinical Advisor


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to AzPA Pharmacy Flash

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of AZPA? Yes   No
Privacy Policy